InsiderFlow

Reshma Rangwala

KPTI

Reshma Rangwala serves as officer: EVP & Chief Medical Officer at Karyopharm Therapeutics Inc. (KPTI). This page tracks their complete SEC Form 4 insider trading history including stock purchases and sales.

Total Buys

0 trades

$0.00

Total Sells

8 trades

$118.7K

Net Position

Net Seller

$118.7K

Companies Traded

1

KPTI

Active Period

Apr 2023 – May 2026

8 total trades

Most Recent

Sell KPTI

May 15, 2026 · $3.9K

Reshma Rangwala's Insider Trading at Karyopharm Therapeutics Inc. (KPTI)

Buys

0 · $0.00

Sells

8 · $118.7K

Total Shares Bought

0

Total Shares Sold

23,896

KPTI Price Chart
Loading chart...
DateTypeValue
May 15, 2026 Sell$3.9K
Apr 22, 2026 Sell$4.0K
Mar 3, 2026 Sell$47.7K
Sep 16, 2025 Sell$2.6K
Apr 24, 2025 Sell$2.6K
Mar 6, 2025 Sell$22.6K
Apr 23, 2024 Sell$7.9K
Apr 24, 2023 Sell$27.4K